UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.762

Sortiert nach

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2362-2371

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e273-e280

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2343-2349

2015

Volltextzugriff (PDF)

A systematic review and meta-analysis of variations in branching patterns of the adult aortic arch

Journal of vascular surgery, 2018-07, Vol.68 (1), p.298-306.e10

2018

Volltextzugriff (PDF)

National population‐based estimates for major birth defects, 2010–2014

Birth defects research, 2019-11, Vol.111 (18), p.1420-1435

2019

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2424-2428

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2350-2355

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2356-2361

2015

Volltextzugriff (PDF)

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports

BMJ (Online), 2015-07, Vol.351, p.h3190

2015

Volltextzugriff (PDF)

Atypical aortic arch branching variants: A novel marker for thoracic aortic disease

The Journal of thoracic and cardiovascular surgery, 2015-06, Vol.149 (6), p.1586-1592

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2412-2423

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e315-e325

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e267-e272

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e256-e261

2015

Volltextzugriff (PDF)

Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study

BMJ (Online), 2020-02, Vol.368, p.m331

2020

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2398

2015

Volltextzugriff (PDF)

Association of aberrant subclavian arteries with aortic pathology and proposed classification system

Journal of vascular surgery, 2020-11, Vol.72 (5), p.1534-1543

2020

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2372-2384

2015

Volltextzugriff (PDF)

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

Psychological medicine, 2010-10, Vol.40 (10), p.1723-1733

2010

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e326-e329

2015

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e292-e297

2015

Volltextzugriff (PDF)

Cardiovascular abnormalities in Klinefelter Syndrome

International journal of cardiology, 2013-09, Vol.168 (2), p.754-759

2013

Volltextzugriff (PDF)

Fetal right aortic arch: associated anomalies, genetic anomalies with chromosomal microarray analysis, and postnatal outcome

Prenatal diagnosis, 2017-04, Vol.37 (4), p.329-335

2017

Volltextzugriff (PDF)

Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia

Circulation (New York, N.Y.), 2007-06, Vol.115 (22), p.2814-2821

2007

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2406-2411

2015

Volltextzugriff (PDF)

1 – 25 von 1.762

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCardiology In The Young

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.708)
Mit Volltextzugriff
(1.570)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.762)
Humans
(1.718)
Female
(1.334)
Cardiovascular System & Cardiology
(1.184)
Male
(1.160)
Cardiac & Cardiovascular Systems
(1.028)
Adult
(682)
Middle Aged
(615)
Risk Factors
(567)
Retrospective Studies
(513)
Biological And Medical Sciences
(452)
Medical Sciences
(443)
Aged
(407)
Infant, Newborn
(399)
Adolescent
(373)
Prevalence
(359)
Child
(351)
Infant
(349)
Heart
(327)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology

A systematic review and meta-analysis of variations in branching patterns of the adult aortic arch

National population‐based estimates for major birth defects, 2010–2014

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology

Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports

Atypical aortic arch branching variants: A novel marker for thoracic aortic disease

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology

Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology

Association of aberrant subclavian arteries with aortic pathology and proposed classification system

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

Cardiovascular abnormalities in Klinefelter Syndrome

Fetal right aortic arch: associated anomalies, genetic anomalies with chromosomal microarray analysis, and postnatal outcome

Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology

Aktive Filter

Suchergebnisse filtern